FDA Type 2a meeting scheduled for November 19, 2025, to review AEON’s analytical development plan and initial data – – Positive biosimilarity data for ABP-450 confirming ...

FDA Type 2a meeting scheduled for November 19, 2025, to review AEON's analytical development plan and initial data - - Positive biosimilarity data for ABP-450 confirming identical amino-acid sequencin ...

Late-breaking results from clinical trials, debates about lifestyle choices and cardiovascular risk, and improving clinical care with generative AI are among the topics being presented by UC San ...

Bilateral trade hits record high as strategic partnership expands into green energy, skilled migration and joint innovation, with over 2,500 German firms now in India ...

Latest deals and offers as they land - We’ve found early discounts on top brands including Ninja, Dyson and more ...

Valeura Energy Inc. (TSX:VLE, OTCQX:VLERF) (“Valeura” or the “Company”) reports its unaudited financial and operating results for the three and nine month periods ended September 30, 2025. Q3 ...

While we continue to see some negative sentiment around ETH due to its decline from nearly $5,000 towards the end of August ...

EcoGraf is pleased to announce the Epanko Graphite Project Expansion Study examined the potential to expand production to support the Company's strategy of developing its commercial scale EcoGraf ...